Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study. - Nguyen O; Wiedrick J; Massera D; Adlestein E; Frejat S; Castrichini M; Alsidawi S; Giudicessi JR; Geske JB; Carrick RT; Madrazo J; Dellise N; et al. (Journal of cardiac failure, 2026)